Alcohol consumption and risk of myelodysplastic syndromes: A metaanalysis of epidemiological studies

By                

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1115-1120

Spandidos Publications

Access to resources Recommend Favorite

Results on efficacy and safety of cancer treatment with or without tumor necrosis factorrelated apoptosisinducing ligandrelated agents: a meta-analysis

By                

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 440-448

Spandidos Publications

Access to resources Recommend Favorite

Novel erythropoiesis stimulating protein (darbepoetin alfa) alleviates anemia associated with chronic inflammatory disease in a rodent model

By Coccia M.A.   Cooke K.   Stoney G.   Pistillo J.   Del Castillo J.   Duryea D.   Tarpley J.E.   Molineux G.  

Experimental Hematology, Vol. 29, Iss. 10, 2001-10 ,pp. : 1201-1209

Elsevier

Access to resources Recommend Favorite

Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes

By Townsley Danielle   Desmond Ronan   Dunbar Cynthia   Young Neal  

International Journal of Hematology, Vol. 98, Iss. 1, 2013-07 ,pp. : 48-55

Springer Publishing Company

Access to resources Recommend Favorite

Biologic and clinical relevance of cytogenetic analysis in primary myelodysplastic syndromes

By Raynaud S.D.  

Pathologie Biologie, Vol. 51, Iss. 6, 2003-08 ,pp. : 346-355

Elsevier

Access to resources Recommend Favorite